In this report, we present a case of CD30+ peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) that emerged one month after the completion of BV-CHP therapy for anaplastic large cell lymphoma (ALCL) and which responded to retreatment with BV monotherapy. The gene discussed is TNFRSF8; the disease is peripheral T-cell lymphoma, not otherwise specified.